Sulodexide improves renal function through reduction of vascular endothelial growth factor in type 2 diabetic rats

Life Sciences

Volumn 92, Issue 23, 2013, Pages 1118-1124

  Cha, Jin Joo ^a   Kang, Young Sun ^a   Hyun, Young Youl ^b   Han, Sang Youb ^c   Jee, Yi Hwa ^a   Han, Kum Hyun ^c   Han, Jee Young ^d   Cha, Dae Ryong ^a  

^a Korea University College of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Inje University   (South Korea)

^d Inha University   (South Korea)

Author keywords

Diabetic nephropathy; Type 2 diabetes mellitus; Vascular endothelial growth factor

Indexed keywords

ALBUMIN; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE P38; SULODEXIDE; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL TYPE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG MECHANISM; GLOMERULUS BASEMENT MEMBRANE; IN VITRO STUDY; KIDNEY FUNCTION; KIDNEY PARENCHYMA; MALE; MORPHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PODOCYTE; PROTEIN SYNTHESIS; RAT; RENAL PROTECTION; URINARY EXCRETION;

ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GLYCOSAMINOGLYCANS; HYPOGLYCEMIC AGENTS; KIDNEY; MALE; RATS; RATS, INBRED OLETF; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 84878568490     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.04.008     Document Type: Article

References (26)

1. L. Adhikary, F. Chow, D.J. Nikolic-Paterson, C. Stambe, J. Dowling, and R.C. Atkins Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy Diabetologia 47 2004 1210 1222
2. L. Braun, T. Kardon, R. Reisz-Porszasz, G. Banhegyi, and J. Mandl The regulation of the induction of vascular endothelial growth factor at the onset of diabetes in spontaneously diabetic rats Life Sci 69 2001 2533 2542
3. D.R. Cha, N.H. Kim, J.W. Yoon, S.K. Jo, W.Y. Cho, and H.K. Kim Role of vascular endothelial growth factor in diabetic nephropathy Kidney Int 58 Suppl. 77 2000 S104 S112
4. D.R. Cha, Y.S. Kang, S.Y. Han, Y.H. Jee, K.H. Han, and J.Y. Han Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats J Endocrinol 183 2004 183 194
5. M. Clauss, M. Gerlach, H. Gerlach, J. Brett, F. Wang, and P.C. Familletti Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cells monocyte procoagulant activity, and promotes monocyte migration J Exp Med 172 1990 1535 1545
6. M.E. Cooper, D. Vranes, S. Youssef, S.A. Stacker, A.J. Cox, and B. Rizkalla Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes Diabetes 48 1999 2229 2239
7. M.C.I.L. Cruz, F.N. Ziyadeh, M. Isono, M. Kouahou, D.C. Han, and R. Kalluri Effects of high glucose and TGF-β1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes Kidney Int 62 2002 901 913
8. T. Dai, R. Natarajan, C.C. Nast, J. LaPage, P. Chuang, and J. Sim Glucose and diabetes: effects on podocyte and glomerular p38 MAPK, heat shock protein 25, and actin cytoskeleton Kidney Int 69 2006 806 814
9. A. De Vriese, R.G. Tilton, M. Elger, C.C. Stephan, W. Kriz, and N.H. Lameire Antibody against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes J Am Soc Nephrol 12 2001 993 1000
10. E. Duh, and L.P. Aiello Vascular endothelial growth factor and diabetes; the agonist versus antagonist paradox Diabetes 48 1999 1899 1906
11. N. Ferrara Role of vascular endothelial growth factor in regulation of angiogenesis Kidney Int 56 1999 794 814
12. G. Gambaro, I. Kinalska, A. Oksa, P. Pont'uch, M. Hertlová, and J. Olsovsky Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial J Am Soc Nephrol 13 2002 1615 1625
13. Y.S. Kang, Y.G. Park, B.K. Kim, S.Y. Han, Y.H. Jee, and K.H. Han Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes J Mol Endocrinol 36 2006 377 388
14. R. Komers, J.N. Lindsley, T.T. Oyama, D.M. Cohen, and S. Anderson Renal p38 MAP kinase activity in experimental diabetes Lab Invest 87 2007 548 558
15. J.M. Kyriakis, and J. Avruch Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation Physiol Rev 81 2001 807 869
16. E.J. Lewis, and X. Xu Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin Diabetes Care 31 Suppl. 2 2008 S202 S207
17. R.J. Ludwig Therapeutic use of heparin beyond anticoagulation Curr Drug Discov Technol 6 2009 281 289
18. W.T. Monacci, M.J. Merrill, and E.H. Oldfield Expression of vascular permeability factor/vascular endothelial growth factor in normal renal tissues Am J Physiol 264 1993 C995 C1002
19. F.A. Ofosu Pharmacological actions of sulodexide Semin Thromb Hemost 24 1998 127 138
20. A. Pletinck, M.V. Landschoot, S. Steppan, D. Laukens, J.P. Deetjen, and R. Vanholder Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion Nephrol Dial Transplant 27 2012 548 556
21. M.J. Rane, Y. Song, S. Jin, M.T. Barati, R. Wu, and H. Kausar Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy Am J Physiol Renal Physiol 298 2010 F49 F61
22. W. Tian, Z. Zhang, and D.M. Cohen MAPK signaling and the kidney Am J Physiol Renal Physiol 279 2000 F593 F604
23. R.G. Tilton, T. Kawamura, K.C. Chang, Y. Ido, R.J. Bjercke, and C.C. Stephan Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor J Clin Invest 99 1997 2192 2202
24. K. Tsuchida, Z. Makita, S. Yamagishi, T. Atsumi, H. Miyoshi, and S. Obara Suppression of transforming growth factor β and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitiorinhibitor, OPB-9195 Diabetologia 42 1999 579 588
25. D. Veron, K.J. Reidy, C. Bertuccio, J. Teichman, G. Villegas, and J. Jimenez Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease Kidney Int 77 2010 989 999
26. D. Veron, C.A. Bertuccio, A. Marlier, K. Reidy, A.M. Garcia, and J. Jimenez Podocyte vascular endothelial growth factor overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes Diabetologia 54 2011 1227 1241